WallStreetZenWallStreetZen

NASDAQ: TPST
Tempest Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for TPST

Based on 1 analyst offering 12 month price targets for Tempest Therapeutics Inc.
Min Forecast
$47.00+1,156.68%
Avg Forecast
$47.00+1,156.68%
Max Forecast
$47.00+1,156.68%

Should I buy or sell TPST stock?

Based on 1 analyst offering ratings for Tempest Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TPST stock forecasts and price targets.

TPST stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-10-11

1 of 1

Forecast return on equity

Is TPST forecast to generate an efficient return?

Forecast return on assets

Is TPST forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.13%

TPST revenue forecast

What is TPST's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$162.2M
Avg 2 year Forecast
$572.0M

TPST vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TPST$3.74$47.00+1,156.68%Buy
KRON$1.23$9.00+631.71%Buy
ELYM$2.60N/AN/A
JSPR$0.65$5.96+817.38%Strong Buy
CRVS$1.48$5.83+294.12%Strong Buy

Tempest Therapeutics Stock Forecast FAQ

Is Tempest Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TPST) stock is to Buy TPST stock.

Out of 1 analyst, 0 (0%) are recommending TPST as a Strong Buy, 1 (100%) are recommending TPST as a Buy, 0 (0%) are recommending TPST as a Hold, 0 (0%) are recommending TPST as a Sell, and 0 (0%) are recommending TPST as a Strong Sell.

If you're new to stock investing, here's how to buy Tempest Therapeutics stock.

What is TPST's revenue growth forecast for 2027-2028?

(NASDAQ: TPST) Tempest Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.56%.

Tempest Therapeutics's revenue in 2023 is $0.On average, 1 Wall Street analysts forecast TPST's revenue for 2027 to be $3,121,943,689, with the lowest TPST revenue forecast at $3,121,943,689, and the highest TPST revenue forecast at $3,121,943,689.

In 2028, TPST is forecast to generate $11,009,567,140 in revenue, with the lowest revenue forecast at $11,009,567,140 and the highest revenue forecast at $11,009,567,140.

What is TPST's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: TPST) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.13%.

What is TPST's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TPST price target, the average TPST price target is $47.00, with the highest TPST stock price forecast at $47.00 and the lowest TPST stock price forecast at $47.00.

The Wall Street analyst predicted that Tempest Therapeutics's share price could reach $47.00 by Oct 11, 2024. The average Tempest Therapeutics stock price prediction forecasts a potential upside of 1,156.68% from the current TPST share price of $3.74.

What is TPST's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: TPST) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.